Precision Business Insights has published a report on the global cell and gene therapy market, estimating its value at USD 27,920 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 20.4% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis...
The Gene Therapy Market is witnessing dynamic growth fueled by scientific breakthroughs, expanding therapeutic indications, and increasing investments. This rapidly evolving market is characterized by intense competition among established pharmaceutical giants, biotechnology innovators, and emerging startups. Strategic alliances and collaborations play a pivotal role in accelerating...
The gene therapy market is undergoing a significant transformation, fueled by rapid advancements in technology and research. Gene therapy, which involves the introduction or alteration of genetic material within a patient’s cells to treat or prevent diseases, has evolved from a niche experimental treatment to a promising mainstream medical option. This shift has been driven by...
The Germany Cell and Gene Therapy CDMO Market is set for remarkable growth, as per the latest insights from Credence Research. Valued at USD 181.63 million in 2024, this market is projected to reach an impressive USD 675.72 million by 2032, reflecting a robust compound annual growth rate. The surge in demand for cell and gene therapy products and the increasing trend of outsourcing development...
The Cell & Gene Therapy Drug Delivery Devices Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s...
Polaris Market Research announces the release of its latest research report titled, Gene Therapy Market. The report offers an in-depth analysis of the global market. It outlines current market conditions and future growth potential over the forecast period. It includes comprehensive data-backed insights into emerging trends, innovation pipelines, and competitive movements to help...
The U.S. Cell and Gene Therapy CDMO Market is driving a revolution in personalized medicine, projected to skyrocket from $2.41 billion in 2024 to $9.53 billion by 2032, exhibiting a robust 17.50% CAGR. This explosive growth is fueled by critical factors like the escalating number of clinical trials, strategic outsourcing for specialized expertise, the adoption of advanced biomanufacturing...
Discover how the UK Cell and Gene Therapy CDMO Market, valued at USD 80.13 million in 2024, is forecast to skyrocket to USD 287.57 million by 2032, driven by a 16.14% CAGR. Learn about the impact of growing demand for advanced therapeutics, expanding biopharma collaborations, technological advancements in manufacturing, and strong UK regulatory support. Gain critical insights from Credence...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek